Cargando…
Successful rechallenge for severe lichenoid drug reaction to pembrolizumab presenting as “toxic epidermal necrolysis-like”
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Libbey Eurotext
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10195128/ https://www.ncbi.nlm.nih.gov/pubmed/36856394 http://dx.doi.org/10.1684/ejd.2022.4378 |
_version_ | 1785044159007031296 |
---|---|
author | Eldani, Céline Darrigade, Anne Sophie Beylot-Barry, Marie Jullie, Marie-Laure Ducharme, Océane Milpied, Brigitte Pham-Ledard, Anne |
author_facet | Eldani, Céline Darrigade, Anne Sophie Beylot-Barry, Marie Jullie, Marie-Laure Ducharme, Océane Milpied, Brigitte Pham-Ledard, Anne |
author_sort | Eldani, Céline |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10195128 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Libbey Eurotext |
record_format | MEDLINE/PubMed |
spelling | pubmed-101951282023-05-19 Successful rechallenge for severe lichenoid drug reaction to pembrolizumab presenting as “toxic epidermal necrolysis-like” Eldani, Céline Darrigade, Anne Sophie Beylot-Barry, Marie Jullie, Marie-Laure Ducharme, Océane Milpied, Brigitte Pham-Ledard, Anne Eur J Dermatol Correspondence John Libbey Eurotext 2023-05-18 2022 /pmc/articles/PMC10195128/ /pubmed/36856394 http://dx.doi.org/10.1684/ejd.2022.4378 Text en © JLE/Springer 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Correspondence Eldani, Céline Darrigade, Anne Sophie Beylot-Barry, Marie Jullie, Marie-Laure Ducharme, Océane Milpied, Brigitte Pham-Ledard, Anne Successful rechallenge for severe lichenoid drug reaction to pembrolizumab presenting as “toxic epidermal necrolysis-like” |
title | Successful rechallenge for severe lichenoid drug reaction to pembrolizumab presenting as “toxic epidermal necrolysis-like” |
title_full | Successful rechallenge for severe lichenoid drug reaction to pembrolizumab presenting as “toxic epidermal necrolysis-like” |
title_fullStr | Successful rechallenge for severe lichenoid drug reaction to pembrolizumab presenting as “toxic epidermal necrolysis-like” |
title_full_unstemmed | Successful rechallenge for severe lichenoid drug reaction to pembrolizumab presenting as “toxic epidermal necrolysis-like” |
title_short | Successful rechallenge for severe lichenoid drug reaction to pembrolizumab presenting as “toxic epidermal necrolysis-like” |
title_sort | successful rechallenge for severe lichenoid drug reaction to pembrolizumab presenting as “toxic epidermal necrolysis-like” |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10195128/ https://www.ncbi.nlm.nih.gov/pubmed/36856394 http://dx.doi.org/10.1684/ejd.2022.4378 |
work_keys_str_mv | AT eldaniceline successfulrechallengeforseverelichenoiddrugreactiontopembrolizumabpresentingastoxicepidermalnecrolysislike AT darrigadeannesophie successfulrechallengeforseverelichenoiddrugreactiontopembrolizumabpresentingastoxicepidermalnecrolysislike AT beylotbarrymarie successfulrechallengeforseverelichenoiddrugreactiontopembrolizumabpresentingastoxicepidermalnecrolysislike AT julliemarielaure successfulrechallengeforseverelichenoiddrugreactiontopembrolizumabpresentingastoxicepidermalnecrolysislike AT ducharmeoceane successfulrechallengeforseverelichenoiddrugreactiontopembrolizumabpresentingastoxicepidermalnecrolysislike AT milpiedbrigitte successfulrechallengeforseverelichenoiddrugreactiontopembrolizumabpresentingastoxicepidermalnecrolysislike AT phamledardanne successfulrechallengeforseverelichenoiddrugreactiontopembrolizumabpresentingastoxicepidermalnecrolysislike |